Commonly used pain relievers have added benefit of fighting bacterial infection

Mar 13, 2014
This image shows nonsteroidal anti-inflammatory drugs bound to bacterial protein. Credit: Aaron Oakley

Some commonly used drugs that combat aches and pains, fever, and inflammation are also thought to have the ability to kill bacteria. New research appearing online on March 13 in the Cell Press journal Chemistry & Biology reveals that these drugs, better known as NSAIDs, act on bacteria in a way that is fundamentally different from current antibiotics. The discovery could open up new strategies for fighting drug-resistant infections and "superbugs."

"We discovered that some anti-inflammatory drugs used in human and veterinary medicine have weak antibiotic activity and that they exert this secondary activity by preventing from copying their DNA, which they need to do in order to multiply," explains senior author Dr. Aaron Oakley of the University of Wollongong, in Australia. The researchers analyzed three NSAIDs: bromofenac, carprofen, and vedaprofen. The more commonly known NSAIDs, which include aspirin, ibuprofen, and naproxen, were not tested.

Dr. Oakley and his team identified that anti-inflammatory drugs bind to and inhibit a specific protein in bacteria called the DNA clamp. The DNA clamp, which is conserved across bacterial species, is part of an enzyme that synthesizes DNA molecules from their nucleotide building blocks.

The discovery comes at a time when there is a pressing need for new classes of antibiotics. "The fact that the bacteria-killing effect of the anti-inflammatory drugs is different from conventional drugs means that the NSAIDS could be developed into new kinds of antibiotics that are effective against so-called superbugs," says Dr. Oakley. "This is important because the have become resistant to many—and in some cases most—of the available antibiotics."

Explore further: FDA advisers revisit heart risks posed by painkillers (Update)

More information: Chemistry & Biology, Yin et al.: "DNA Replication is the Target for the Antibacterial Effects of Non-Steroidal Anti-Inflammatory Drugs." dx.doi.org/10.1016/j.chembiol.2014.02.009

add to favorites email to friend print save as pdf

Related Stories

Chemists discover new class of antibiotics

Mar 07, 2014

(Phys.org) —A team of University of Notre Dame researchers led by Mayland Chang and Shahriar Mobashery have discovered a new class of antibiotics to fight bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) ...

Recommended for you

Two teams pave way for advances in 2D materials

2 hours ago

This month's headlines on two-dimensional polymers showed noteworthy headway. "2-D Polymer Crystals Confirmed At Last," said Chemical & Engineering News. "Engineers Make the World's First Verified, 2-Dimensional P ...

Nature inspires a greener way to make colorful plastics

21 hours ago

Long before humans figured out how to create colors, nature had already perfected the process—think stunning, bright butterfly wings of many different hues, for example. Now scientists are tapping into ...

New catalyst converts carbon dioxide to fuel

23 hours ago

Scientists from the University of Illinois at Chicago have synthesized a catalyst that improves their system for converting waste carbon dioxide into syngas, a precursor of gasoline and other energy-rich products, bringing ...

User comments : 0